An open-label study of liquid and sprinkled formulations of Efavirenz administered in combination with Didanosine and Emtricitabine in HIV-infected infants and children 3 months to 6 years of age

Project no.: HIV-NAT 090

This study will evaluate the pharmacokinetic and efficacy of efavirenz in HIV-infected children.

Publications: in JAIDS review